Skip to main content
Institute for Global Health & Infectious Diseases

2021

  1. Apornpong T, Grinsztejn B, Hughes M, Ritz J, Kerr SJ, Fletcher CV, et al. Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settings. AIDS. 2021 Jul 15;35(9):1439–49.
  2. Bono SA, Faria de Moura Villela E, Siau CS, Chen WS, Pengpid S, Hasan MT, et al. Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries. Vaccines. 2021 May 17;9(5):515.
  3. Bono SA, Siau CS, Chen WS, Low WY, Faria de Moura Villela E, Pengpid S, et al. Adults’ Acceptance of COVID-19 Vaccine for Children in Selected Lower- and Middle-Income Countries. Vaccines. 2021 Dec 22;10(1):11.
  4. Burke RM, Rickman HM, Singh V, Corbett EL, Ayles H, Jahn A, et al. What is the optimum time to start antiretroviral therapy in people with HIV and tuberculosis coinfection? A systematic review and meta‐analysis. J Int AIDS Soc [Internet]. 2021 Jul [cited 2022 Jan 14];24(7). Available from: https://onlinelibrary.wiley.com/doi/10.1002/jia2.25772
  5. Chagomerana MB, Edwards JK, Zalla LC, Carbone NB, Banda GT, Mofolo IA, et al. Timing of HIV testing among pregnant and breastfeeding women and risk of mother‐to‐child HIV transmission in Malawi: a sampling‐based cohort study. J Int AIDS Soc [Internet]. 2021 Mar [cited 2022 Jan 14];24(3). Available from: https://onlinelibrary.wiley.com/doi/10.1002/jia2.25687
  6. Chagomerana MB, Hosseinipour MC, Pilotto JH, Badal-Faesen S, Nyirenda M, Shava E, et al. Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052. Int J STD AIDS. 2021 Nov;32(13):1204–11.
  7. Chen JS, Matoga M, Pence BW, Powers KA, Maierhofer CN, Jere E, et al. A randomized controlled trial evaluating combination detection of HIV in Malawian sexually transmitted infections clinics. J Int AIDS Soc [Internet]. 2021 Apr [cited 2022 Jan 14];24(4). Available from: https://onlinelibrary.wiley.com/doi/10.1002/jia2.25701
  8. Chinula L, Topazian HM, Mapanje C, Varela A, Chapola J, Limarzi L, et al. Uptake and safety of community‐based “screen‐and‐treat” with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi. Int J Cancer. 2021 Jul 15;149(2):371–7.
  9. Dussault JM, Zimba C, Malava J, Akello H, Stockton MA, Udedi M, et al. “Thandi should feel embarrassed”: describing the validity and reliability of a tool to measure depression-related stigma among patients with depressive symptoms in Malawi. Soc Psychiatry Psychiatr Epidemiol [Internet]. 2021 Nov 20 [cited 2022 Jan 14]; Available from: https://link.springer.com/10.1007/s00127-021-02202-w
  10. Gatechompol S, Zheng L, Bao Y, Avihingsanon A, Kerr SJ, Kumarasamy N, et al. Prevalence and risk of residual viremia after ART in low- and middle-income countries: A cross-sectional study. Medicine (Baltimore). 2021 Sep 3;100(35):e26817.
  11. Gaynes BN, Akiba CF, Hosseinipour MC, Kulisewa K, Amberbir A, Udedi M, et al. The Sub-Saharan Africa Regional Partnership (SHARP) for Mental Health Capacity-Building Scale-Up Trial: Study Design and Protocol. Psychiatr Serv. 2021 Jul 1;72(7):812–21.
  12. Gondwe A, Amberbir A, Singogo E, Berman J, Singano V, Theu J, et al. Prisoners’ access to HIV services in southern Malawi: a cross-sectional mixed methods study. BMC Public Health. 2021 Dec;21(1):813.
  13. Harrington BJ, Klyn LL, Ruegsegger LM, Thom A, Jumbe AN, Maliwichi M, et al. Locally contextualizing understandings of depression, the EPDS, and PHQ-9 among a sample of postpartum women living with HIV in Malawi. J Affect Disord. 2021 Feb;281:958–66.
  14. Herce ME, Chagomerana MB, Zalla LC, Carbone NB, Chi BH, Eliya MT, et al. Community-facility linkage models and maternal and infant health outcomes in Malawi’s PMTCT/ART program: A cohort study. Newell M-L, editor. PLOS Med. 2021 Sep 17;18(9):e1003780.
  15. Hosseinipour MC, Innes C, Naidoo S, Mann P, Hutter J, Ramjee G, et al. Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein. Clin Infect Dis. 2020 Jan 4;ciz1239.
  16. Kalata N, Ellis J, Kanyama C, Kuoanfank C, Temfack E, Mfinanga S, et al. Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy–Naïve and –Experienced Patients in Sub-Saharan Africa. Open Forum Infect Dis. 2021 Oct 1;8(10):ofab397.
  17. Kapito-Tembo AP, Bauleni A, Wesevich A, Ongubo D, Hosseinipour MC, Dube Q, et al. Growth and Neurodevelopment Outcomes in HIV-, Tenofovir-, and Efavirenz-Exposed Breastfed Infants in the PMTCT Option B+ Program in Malawi. JAIDS J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):81–90.
  18. Krishnan S, Queiroz ATL, Gupta A, Gupte N, Bisson GP, Kumwenda J, et al. Integrative Multi-Omics Reveals Serum Markers of Tuberculosis in Advanced HIV. Front Immunol. 2021 Jun 8;12:676980.
  19. Matoga M, Hosseinipour MC, Jewett S, Hoffman IF, Chasela C. Effects of HIV voluntary medical male circumcision programs on sexually transmitted infections. Curr Opin Infect Dis. 2021 Feb;34(1):50–5.
  20. Matoga MM, Bisson GP, Gupta A, Miyahara S, Sun X, Fry C, et al. Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy. Clin Infect Dis. 2021 Aug 16;73(4):e870–7.
  21. Molloy SF, Ross B, Kanyama C, Mfinanga S, Lesikari S, Heyderman RS, et al. Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis. Open Forum Infect Dis. 2021 Apr 1;8(4):ofab066.
  22. Muula AS, Hosseinipour MC, Makwero M, Kumwenda J, Lutala P, Mbeba M, et al. Mentoring upcoming researchers for non-communicable diseases’ research and practice in Malawi. Trials. 2021 Dec;22(1):65.
  23. Ruegsegger LM, Stockton M, Go VF, Piscalko H, Davis D, Hoffman IF, et al. Stigma, Social Support, and Sexual Behavior Among Female Sex Workers at Risk for HIV in Malawi. AIDS Educ Prev. 2021 Aug;33(4):290–302.
  24. Seneviratne HK, Hamlin AN, Li S, Grinsztejn B, Dawood H, Liu AY, et al. Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study. ACS Pharmacol Transl Sci. 2021 Feb 12;4(1):226–39.
  25. Stockton MA, Gaynes BN, Hosseinipour MC, Pettifor AE, Maselko J, Mphonda SM, et al. Association Between Depression and HIV Care Engagement Outcomes Among Patients Newly Initiating ART in Lilongwe, Malawi. AIDS Behav. 2021 Mar;25(3):826–35.
  26. Stockton MA, Minnick CE, Kulisewa K, Mphonda SM, Hosseinipour MC, Gaynes BN, et al. A Mixed-Methods Process Evaluation: Integrating Depression Treatment Into HIV Care in Malawi. Glob Health Sci Pract. 2021 Sep 30;9(3):611–25.
  27. Zhang Y, Wymant C, Laeyendecker O, Grabowski MK, Hall M, Hudelson S, et al. Evaluation of Phylogenetic Methods for Inferring the Direction of Human Immunodeficiency Virus (HIV) Transmission: HIV Prevention Trials Network (HPTN) 052. Clin Infect Dis. 2020 Feb 7;ciz1247.
  28. Zimba CC, Akiba CF, Matewere M, Thom A, Udedi M, Masiye JK, et al. Facilitators, barriers and potential solutions to the integration of depression and non-communicable diseases (NCDs) care in Malawi: a qualitative study with service providers. Int J Ment Health Syst. 2021 Dec;15(1):59.
  29. Baeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G, et al. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. Lancet HIV. 2021 Feb;8(2):e87–95.
  30. Bula AK, Hatfield-Timajchy K, Chapola J, Chinula L, Hurst SA, Kourtis AP, et al. Motivations to use hormonal contraceptive methods and condoms among HIV-positive and negative women randomized to a progestin contraceptive in Malawi: a qualitative study. BMC Womens Health. 2021 Dec;21(1):114.
  31. Chapola JC, Hatfield-Timajchy K, Bula AK, Hurst S, Chinula L, Kourtis AP, et al. Women’s perspectives on relationship dynamics with their partners and their role in HIV acquisition, HIV disclosure, hormonal contraceptive uptake, and condom use. Afr J AIDS Res. 2021 Jan 2;20(1):61–9.
  32. Chapola J, Lee F, Bula A, Mapanje C, Phiri BR, Kamtuwange N, et al. Barriers to follow-up after an abnormal cervical cancer screening result and the role of male partners: a qualitative study. BMJ Open. 2021 Sep;11(9):e049901.
  33. Klyn LL, Chapola J, Mapanje C, Bula A, Tang JH, Gopal S, et al. Lessons learned from a rural, community-based cervical cancer screen-and-treat pilot study in Malawi. Public Health Pract. 2021 Nov;2:100110.
  34. Lee F, Bula A, Chapola J, Mapanje C, Phiri B, Kamtuwange N, et al. Women’s experiences in a community-based screen-and-treat cervical cancer prevention program in rural Malawi: a qualitative study. BMC Cancer. 2021 Dec;21(1):428.
  35. Lockman S, Brummel SS, Ziemba L, Stranix-Chibanda L, McCarthy K, Coletti A, et al. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. The Lancet. 2021 Apr;397(10281):1276–92.
  36. Ngene NC, Moodley J, Chinula L, Matjila M. The effects of mode of delivery on causes of postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol. 2021 Sep;264:388.
  37. Saidi F, Rajab B, Chinula L, Kafumba N, Chagomerana M, Tang JH. Term gravid uterus in a congenital umbilical hernia: a case report. J Med Case Reports. 2021 Dec;15(1):187.
  38. Shah SK, London AJ, Mofenson L, Lavery JV, John-Stewart G, Flynn P, et al. Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention Trial. Clin Trials. 2021 Dec;18(6):681–9.
  39. Stoner MCD, Brown ER, Palanee-Phillips T, Mansoor LE, Tembo T, Nair G, et al. The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence. AIDS Behav. 2021 Dec;25(12):4169–79.
  40. Tang JH, Smith JS, McGue S, Gadama L, Mwapasa V, Chipeta E, et al. Prevention of cervical cancer through two HPV-based screen-and-treat implementation models in Malawi: protocol for a cluster randomized feasibility trial. Pilot Feasibility Stud. 2021 Dec;7(1):98.
  41. Theron G, Brummel S, Fairlie L, Pinilla M, McCarthy K, Owor M, et al. Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy (ART) Compared to Those Commenced on ART During Pregnancy. Clin Infect Dis. 2021 Jul 15;73(2):e312–20.
  42. Zia Y, Davis N, Wiener J, Hobbs MM, Lapple D, Chinula L, et al. Factors associated with vaginal detection of prostate-specific antigen among participants in a clinical trial in Malawi. Sex Transm Infect. 2021 Feb;97(1):77–77.
  43. Bell GJ, Agnandji ST, Asante KP, Ghansah A, Kamthunzi P, Emch M, et al. Impacts of Ecology, Parasite Antigenic Variation, and Human Genetics on RTS,S/AS01e Malaria Vaccine Efficacy. Curr Epidemiol Rep. 2021 Sep;8(3):79–88.
  44. Kamthunzi P. Impact of PCV13 vaccination in Blantyre, Malawi. Lancet Glob Health. 2021 Jul;9(7):e893–4.
  45. Libous JL, Montañez NA, Dow DE, Kapetanovic S, Buckley J, Kakhu TJ, et al. IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes of Implementation. Front Reprod Health. 2021 May 28;3:662912.
  46. Mathad JS, Savic R, Britto P, Jayachandran P, Wiesner L, Montepiedra G, et al. Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women. Clin Infect Dis. 2021 Jul 29;ciab665.
  47. Owor M, Tierney C, Ziemba L, Browning R, Moye J, Graham B, et al. Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092. Pediatr Infect Dis J. 2021 May;40(5):446–52.
  48. Tegha G, Topazian HM, Kamthunzi P, Howard T, Tembo Z, Mvalo T, et al. Prospective Newborn Screening for Sickle Cell Disease and Other Inherited Blood Disorders in Central Malawi. Int J Public Health. 2021 Jun 29;66:629338.
  49. Gadama D, Mvalo T, Ginsburg AS. Haemophilus influenzae type b and pneumococcal conjugate vaccination coverage in children aged 2-59 months in Malawi. Hum Vaccines Immunother. 2021 Feb 1;17(2):397–9.
  50. Ginsburg AS, Mvalo T, Hwang J, Phiri M, McCollum ED, Maliwichi M, et al. Malawian children with fast-breathing pneumonia with and without comorbidities. Pneumonia. 2021 Dec;13(1):3.
  51. Ginsburg AS, Mvalo T, May S. Repeat assessment of physical examination findings among HIV-uninfected children in Malawi with chest-indrawing pneumonia. Int J Infect Dis. 2021 Sep;110:371–3.
  52. Ginsburg AS, Mvalo T, Phiri M, Gadama D, Chirombo C, Maliwichi M, et al. Malawian children with chest-indrawing pneumonia with and without comorbidities or danger signs. J Glob Health. 2021 Mar 7;11:04016.
  53. Gumbo A, Topazian HM, Mwanza A, Mitchell CL, Puerto-Meredith S, Njiko R, et al. Occurrence and Distribution of Nonfalciparum Malaria Parasite Species Among Adolescents and Adults in Malawi. J Infect Dis. 2021 Jul 9;jiab353.
  54. Keating EM, Chiume M, Fitzgerald E, Mgusha Y, Mvalo T, Fino N, et al. Blood transfusion and mortality in children with severe anaemia in a malaria-endemic region. Paediatr Int Child Health. 2021 Apr 3;41(2):129–36.
  55. North K, Bellad RM, Bose C, Dhaded SM, Goudar SS, Herekar V, et al. Implementing the Dubowitz assessment of gestational age in India and Malawi: a cross-sectional study of participants in a training workshop. J Glob Health Rep [Internet]. 2021 Aug 24 [cited 2022 Jan 14]; Available from: https://www.joghr.org/article/25975-implementing-the-dubowitz-assessment-of-gestational-age-in-india-and-malawi-a-cross-sectional-study-of-participants-in-a-training-workshop
  56. Sessions KL, Smith AG, Holmberg PJ, Wahl B, Mvalo T, Chisti MJ, et al. Continuous positive airway pressure for children in resource-limited settings, effect on mortality and adverse events: systematic review and meta-analysis. Arch Dis Child. 2021 Dec 8;archdischild-2021-323041.
  57. Topazian HM, Gumbo A, Brandt K, Kayange M, Smith JS, Edwards JK, et al. Effectiveness of a national mass distribution campaign of long-lasting insecticide-treated nets and indoor residual spraying on clinical malaria in Malawi, 2018–2020. BMJ Glob Health. 2021 May;6(5):e005447.
  58. Vesel L, Spigel L, Behera JN, Bellad RM, Das L, Dhaded S, et al. Mixed-methods, descriptive and observational cohort study examining feeding and growth patterns among low birthweight infants in India, Malawi and Tanzania: the LIFE study protocol. BMJ Open. 2021 Dec;11(12):e048216.
  59. Meya DB, Tugume L, Nabitaka V, Namuwenge P, Phiri S, Oladele R, et al. Establishing targets for advanced HIV disease: A call to action. South Afr J HIV Med [Internet]. 2021 Aug 10 [cited 2022 Jan 14];22(1). Available from: https://sajhivmed.org.za/index.php/hivmed/article/view/1266
  60. Podany AT, Leon-Cruz J, Hakim J, Supparatpinyo K, Omoz-Oarhe A, Langat D, et al. Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention. J Antimicrob Chemother. 2021 Feb 11;76(3):718–21.
  61. Matoga M, Chen JS, Kudowa E, Kamanga G, Mapanje C, Massa C, et al. Syndromes Associated with Sexually Transmitted Infections in Lilongwe, Malawi: Burden and Trends, 2006-2015. Sex Transm Dis [Internet]. 2020 Sep 8 [cited 2022 Jan 14];Publish Ahead of Print. Available from: https://journals.lww.com/10.1097/OLQ.0000000000001278
  62. Montaño MA, Chagomerana MB, Borok M, Painschab M, Uldrick TS, Bender Ignacio RA. Impact of Antiretroviral Therapy on Cancer Treatment Outcomes among People Living with HIV in Low- and Middle-Income Countries: a Systematic Review. Curr HIV/AIDS Rep. 2021 Apr;18(2):105–16.
  63. Brummel SS, Taha TE, Saidi F, Atuhaire P, Dula D, Moodley D, et al. Impact of ART on Maternal Health After Cessation of Breastfeeding. J Acquir Immune Defic Syndr. 2020;86(4):5.
  64. Hill LM, Saidi F, Freeborn K, Amico KR, Rosenberg NE, Maman S, et al. Tonse Pamodzi: Developing a combination strategy to support adherence to antiretroviral therapy and HIV pre-exposure prophylaxis during pregnancy and breastfeeding. Price MA, editor. PLOS ONE. 2021 Jun 25;16(6):e0253280.
  65. Mutale W, Freeborn K, Graybill LA, Lusaka MM, Mollan KR, Mweemba O, et al. Addition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia: two parallel randomised trials. Lancet Glob Health. 2021 Dec;9(12):e1719–29.
  66. Saidi F, Mutale W, Freeborn K, Rosenberg NE, Graybill LA, Maman S, et al. Combination adherence strategy to support HIV antiretroviral therapy and pre-exposure prophylaxis adherence during pregnancy and breastfeeding: protocol for a pair of pilot randomised trials. BMJ Open. 2021 Jun;11(6):e046032.
  67. Tobin NH, Murphy A, Li F, Brummel SS, Taha TE, Saidi F, et al. Comparison of dried blood spot and plasma sampling for untargeted metabolomics. Metabolomics. 2021 Jul;17(7):62.
  68. Chen JS, Matoga M, Massa C, Tegha G, Ndalama B, Bonongwe N, et al. Effects of Urethritis on Human Immunodeficiency Virus (HIV) in Semen: Implications for HIV Prevention and Cure. Clin Infect Dis. 2021 Oct 5;73(7):e2000–4.
  69. Dooley KE, Rosenkranz SL, Conradie F, Moran L, Hafner R, von Groote-Bidlingmaier F, et al. QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial. Lancet Infect Dis. 2021 Jul;21(7):975–83.
  70. Tegha G, Ciccone EJ, Krysiak R, Kaphatika J, Chikaonda T, Ndhlovu I, et al. Genomic epidemiology of Escherichia coli isolates from a tertiary referral center in Lilongwe, Malawi. Microb Genomics [Internet]. 2021 Jan 1 [cited 2022 Jan 14];7(1). Available from: https://www.microbiologyresearch.org/content/journal/mgen/10.1099/mgen.0.000490
  71. Asuquo SE, Tahlil KM, Muessig KE, Conserve DF, Igbokwe MA, Chima KP, et al. Youth engagement in HIV prevention intervention research in sub‐Saharan Africa: a scoping review. J Int AIDS Soc [Internet]. 2021 Feb [cited 2022 Jan 14];24(2). Available from: https://onlinelibrary.wiley.com/doi/10.1002/jia2.25666
  72. Bhushan NL, Fisher EB, Gottfredson NC, Maman S, Speizer IS, Phanga T, et al. The mediating role of partner communication on contraceptive use among adolescent girls and young women participating in a small-group intervention in Malawi: A longitudinal analysis. Glob Public Health. 2021 May 12;1–14.
  73. Bhushan NL, Fisher EB, Maman S, Speizer IS, Gottfredson NC, Phanga T, et al. Communication, social norms, and contraceptive use among adolescent girls and young women in Lilongwe, Malawi. Women Health. 2021 May 28;61(5):440–51.
  74. Bhushan NL, Phanga T, Maseko B, Vansia D, Kamtsendero L, Gichane MW, et al. Contraceptive Conversations among Adolescent Girls and Young Women and Their Partners, Peers, and Older Female Family Members in Lilongwe, Malawi: A Qualitative Analysis. Stud Fam Plann. 2021 Dec;52(4):397–413.
  75. Gichane MW, Rosenberg NE, Zimmer C, Pettifor AE, Maman S, Maseko B, et al. Individual and Relationship-Level Correlates of Transactional Sex Among Adolescent Girls and Young Women in Malawi: A Multilevel Analysis. AIDS Behav [Internet]. 2021 Aug 23 [cited 2022 Jan 14]; Available from: https://link.springer.com/10.1007/s10461-021-03442-2
  76. Mweemba O, Zimba C, Chi BH, Chibwe KF, Dunda W, Freeborn K, et al. Contextualising men’s role and participation in PMTCT programmes in Malawi and Zambia: A hegemonic masculinity perspective. Glob Public Health. 2021 Aug 10;1–14.
  77. Tembo TA, Simon KR, Kim MH, Chikoti C, Huffstetler HE, Ahmed S, et al. Pilot-Testing a Blended Learning Package for Health Care Workers to Improve Index Testing Services in Southern Malawi: An Implementation Science Study. JAIDS J Acquir Immune Defic Syndr. 2021 Dec 15;88(5):470–6.
  78. Etima J, Katz AWK, Duby Z, Garcia M, Palanee-Phillips T, Reddy K, et al. Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial. AIDS Behav [Internet]. 2021 Nov 2 [cited 2022 Jan 14]; Available from: https://link.springer.com/10.1007/s10461-021-03512-5
  79. Gichane MW, Katz AWK, Ngure K, Scheckter R, Woeber K, Reddy K, et al. Impact of Women’s Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa. AIDS Behav. 2021 Dec;25(12):3847–57.
  80. Leslie J, Kiweewa F, Palanee-Phillips T, Bunge K, Mhlanga F, Kamira B, et al. Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa. BMC Womens Health. 2021 Dec;21(1):175.
  81. Naidoo K, Mansoor LE, Katz AWK, Garcia M, Kemigisha D, Morar NS, et al. Qualitative Perceptions of Dapivirine VR Adherence and Drug Level Feedback Following an Open-Label Extension Trial. JAIDS J Acquir Immune Defic Syndr. 2021 Apr 1;86(4):e90–6.
  82. Naslund JA, Kalha J, Restivo JL, Amarreh I, Callands T, Chen H, et al. Identifying challenges and recommendations for advancing global mental health implementation research: A key informant study of the National Institute of Mental Health Scale-Up Hubs. Asian J Psychiatry. 2021 Mar;57:102557.
  83. Parikh UM, Penrose KJ, Heaps AL, Halvas EK, Goetz BJ, Gordon KC, et al. HIV‐1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial. J Int AIDS Soc [Internet]. 2021 Nov [cited 2022 Jan 14];24(11). Available from: https://onlinelibrary.wiley.com/doi/10.1002/jia2.25833
  84. Zimba C, Sherwood G, Mark B, Leeman J. Supporting the implementation of guidelines to prevent mother-to-child-transmission of HIV in Malawi: a multi-case study. Malawi Med J. 2021 Sep 27;33(3):178–85.
  85. Anderson DM, Cronk R, Pak E, Malima P, Fuente D, Tracy JW, et al. Development and application of tools to cost the delivery of environmental health services in healthcare facilities: a financial analysis in urban Malawi. BMC Health Serv Res. 2021 Dec;21(1):329.
  86. Matoga M, Chen JS, Krysiak R, Ndalama B, Massa C, Bonongwe N, et al. Gentamicin susceptibility in Neisseria gonorrhoeae and treatment outcomes for urogenital gonorrhea after twenty-five years of sustained gentamicin use in Malawi. Sex Transm Dis [Internet]. 2021 Nov 10 [cited 2022 Jan 14];Publish Ahead of Print. Available from: https://journals.lww.com/10.1097/OLQ.0000000000001580
  87. Garcia M, Luecke E, Mayo AJ, Scheckter R, Ndase P, Kiweewa FM, et al. Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study. BMC Public Health. 2021 Dec;21(1):2041.
  88. Mayo AJ, Browne EN, Montgomery ET, Torjesen K, Palanee-Phillips T, Jeenarain N, et al. Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial. AIDS Behav. 2021 Aug;25(8):2430–40.
  89. Peebles K, Kiweewa FM, Palanee-Phillips T, Chappell C, Singh D, Bunge KE, et al. Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study. Clin Infect Dis. 2021 Aug 2;73(3):513–20.
  90. Jacobson C, Moodley J, Bhoola A, Sakwa R, Moodley J, Sukdao J, et al. Strategies implemented for accurate dispensing of an investigational new drug in a multi-site HIV prevention clinical trial. Contemp Clin Trials Commun. 2021 Dec;24:100859.
  91. Kimani S, Painschab MS, Kaimila B, Kasonkanji E, Zuze T, Tomoka T, et al. Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial. Lancet Glob Health. 2021 Jul;9(7):e1008–16.
  92. Painschab MS, Kohler R, Kimani S, Mhango W, Kaimila B, Zuze T, et al. Comparison of best supportive care, CHOP, or R-CHOP for treatment of diffuse large B-cell lymphoma in Malawi: a cost-effectiveness analysis. Lancet Glob Health. 2021 Sep;9(9):e1305–13.
  93. Ellis GK, Manda A, Topazian H, Stanley CC, Seguin R, Minnick CE, et al. Feasibility of upfront mobile money transfers for transportation reimbursement to promote retention among patients receiving lymphoma treatment in Malawi. Int Health. 2021 Apr 27;13(3):297–304.
  94. Ellis GK, Chapman H, Manda A, Salima A, Itimu S, Banda G, et al. Pediatric lymphoma patients in Malawi present with poor health‐related quality of life at diagnosis and improve throughout treatment and follow‐up across all Pediatric PROMIS‐25 domains. Pediatr Blood Cancer [Internet]. 2021 Oct [cited 2022 Jan 14];68(10). Available from: https://onlinelibrary.wiley.com/doi/10.1002/pbc.29257
  95. Agwu C, Purcell LN, Gallaher J, Young S, Banza L, Mansfield AJ, et al. Cost-Effectiveness analysis of the surgical management of fractures in Malawi: An economic evaluation of a high and low-income country surgical collaboration. Injury. 2021 Apr;52(4):767–73.
  96. Akinkuotu AC, Purcell LN, Kayange L, Phillips MR, Hayes-Jordan A, Charles AG. Trends and outcomes following intentional injuries in pediatric patients in a resource-limited setting. Pediatr Surg Int. 2021 May;37(5):649–57.
  97. An SJ, Purcell LN, Mulima G, Charles AG. Characteristics and outcomes following motorized and non-motorized vehicular trauma in a resource-limited setting. Injury. 2021 Sep;52(9):2645–50.
  98. Azad AD, Charles AG, Ding Q, Trickey AW, Wren SM. The gender gap and healthcare: associations between gender roles and factors affecting healthcare access in Central Malawi, June–August 2017. Arch Public Health. 2020 Dec;78(1):119.
  99. Bjornstad EC, Smith ZH, Muronya W, Munthali CK, Mottl AK, Marshall SW, et al. High risk of acute kidney injury in Malawian trauma patients: a prospective observational cohort study. BMC Nephrol. 2021 Dec;22(1):354.
  100. Gallaher J, Kayange L, Purcell LN, Reid T, Charles A. Are Surgeons Enough? The Relationship between Increasing Surgical Demand and Access to Surgery in a Resource-Limited Environment. J Surg Res. 2021 Nov;267:569–76.
  101. Gallaher J, Purcell LN, Banda W, Reid T, Charles A. Re-evaluation of the Effect of Age on In-hospital Burn Mortality in a Resource-Limited Setting. J Surg Res. 2021 Feb;258:265–71.
  102. Gallaher J, Purcell LN, Banda W, Reid T, Charles A. The Association Between Burn Unit Census and Operative Intervention in a Resource-Limited Setting. World J Surg. 2021 Jun;45(6):1686–91.
  103. Gallaher JR, Banda W, Lachiewicz AM, Krysiak R, Purcell LN, Charles AG. Predictors of multi-drug resistance in burn wound colonization following burn injury in a resource-limited setting. Burns. 2021 Sep;47(6):1308–13.
  104. Gallaher JR, Chise Y, Reiss R, Purcell LN, Manjolo M, Charles A. Underutilization of Operative Capacity at the District Hospital Level in a Resource-Limited Setting. J Surg Res. 2021 Mar;259:130–6.
  105. Gallaher JR, Yohann A, Purcell LN, Kumwenda K-K, Charles A. Trends in head injury associated mortality in Malawi. Injury. 2021 May;52(5):1170–5.
  106. Mulima G, Purcell LN, Maine R, Bjornstad EC, Charles A. Epidemiology of prehospital trauma deaths in Malawi: A retrospective cohort study. Afr J Emerg Med. 2021 Jun;11(2):258–62.
  107. Prin M, Kaizer A, Cardenas J, Mtalimanja O, Kadyaudzu C, Charles A, et al. Tracheostomy Practices for Mechanically Ventilated Patients in Malawi. World J Surg. 2021 Sep;45(9):2638–42.
  108. Prin M, Rui S, Pan S, Kadyaudzu C, Mehta PS, Li G, et al. Anemia at Intensive Care Unit Admission and Hospital Mortality Among Patients at a Referral Hospital in Malawi. Am Surg. 2021 Aug;87(8):1334–40.
  109. Purcell LN, Banda W, Akinkuotu A, Phillips M, Hayes-Jordan A, Charles A. Characteristics and predictors of mortality in-hospital mortality following burn injury in infants in a resource-limited setting. Burns. 2021 Jul;S0305417921001741.
  110. Purcell LN, Ellis D, Reid T, Mabedi C, Maine R, Charles A. In-home interpersonal violence: Sex based prevalence and outcomes. Afr J Emerg Med. 2021 Mar;11(1):93–7.
  111. Purcell LN, Mulima G, Nip E, Yohan A, Gallaher J, Charles A. Police Transportation Following Vehicular Trauma and Risk of Mortality in a Resource-Limited Setting. World J Surg. 2021 Mar;45(3):662–7.
  112. Purcell LN, Reiss R, Mtalimanja M, Kuyenda P, Msosa V, Westmoreland KD, et al. Patient-Reported Quality of Life Following Laparotomy in a Resource-Limited Setting. World J Surg. 2021 Jul;45(7):1971–8.
  113. Purcell LN, Sincavage J, Banda W, Cairns B, Phillips MR, Gallaher JR, et al. The effect of burn mechanism on pediatric mortality in Malawi: A propensity weighted analysis. Burns. 2021 Feb;47(1):222–7.
  114. Purcell LN, Yohann A, Banda W, Gallaher J, Charles A. Sex dimorphism in pediatric burn mortality in Malawi: A propensity matched analysis. Burns. 2021 Feb;47(1):228–33.
  115. Robinson B, Purcell LN, Kajombo C, Gallaher J, Charles A. Outcomes of stab wounds presenting to Kamuzu Central Hospital in Malawi. Malawi Med J. 2021;6.
  116. Sincavage J, Robinson B, Msosa VJ, Katete C, Purcell LN, Charles A. Preoperative anemia and surgical outcomes following laparotomy in a resource-limited setting. Am J Surg. 2021 Aug;222(2):424–30.
  117. Williams BM, Purcell LN, Varela C, Gallaher J, Charles A. Non reducible inguinal hernias in Malawi: an occupational hazard. Hernia. 2021 Oct;25(5):1339–44.
  118. Williams BM, Kayange L, Purcell L, Gallaher J, Charles A. Self-inflicted injuries: The intersection of mental health and traumatic injury in Malawi. Trop Doct. 2021 Jul;51(3):390–7.
  119. Williams BM, Kayange L, Purcell L, Charles A, Gallaher J. Elderly trauma mortality in a resource-limited setting: A benchmark for process improvement. Injury. 2021 Sep;52(9):2651–6.
  120. Williams BM, Purcell L, Kayange L, Gallaher J, Charles A. Characteristic and outcomes of human and animal bites in Malawi. Injury. 2021 Aug;52(8):2188–93.
  121. Williams BM, Purcell LN, Varela C, Gallaher J, Charles A. Appendicitis Mortality in a Resource-Limited Setting: Issues of Access and Failure to Rescue. J Surg Res. 2021 Mar;259:320–5.
  122. Yohann A, Kratzke I, Williams B, Charles A. The effect of transfer status on trauma outcomes in low- and middle-income countries: A systematic review and meta-analysis. Injury. 2021 Oct;S0020138321008780.
  123. Bhattacharya D, Gupta A, Tierney C, Huang S, Peters MG, Chipato T, et al. Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens. Clin Infect Dis. 2021 Apr 26;72(8):1342–9.
  124. Flynn PM, Taha TE, Cababasay M, Butler K, Fowler MG, Mofenson LM, et al. Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component. JAIDS J Acquir Immune Defic Syndr. 2021 Oct 1;88(2):206–13.
  125. Frascino NY, Edwards JK, Herce ME, Maselko J, Pettifor AE, Mbeye N, et al. Differences in Access to HIV Services and Risky Sexual Behaviors Among Malawian Women at Social Venues Who Do and Do Not Engage in Sex Work. AIDS Behav. 2021 Sep;25(9):2920–8.
  126. Vonasek BJ, Mhango S, Crouse HL, Nyangulu T, Gaven W, Ciccone E, et al. Improving recognition and management of children with complicated severe acute malnutrition at a tertiary referral hospital in Malawi: a quality improvement initiative. Paediatr Int Child Health. 2021 Jul 3;41(3):177–87.
  127. Deeks SG, Archin N, Cannon P, Collins S, Jones RB, de Jong MAWP, et al. Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021. Nat Med. 2021 Dec;27(12):2085–98.
  128. Banda C, Nayupe SF, Munharo S, Patel P, Mbulaje P. Factors affecting viral load testing turnaround time in Malawi. PAMJ – One Health [Internet]. 2021 [cited 2022 Jan 14];6. Available from: https://www.one-health.panafrican-med-journal.com/content/article/6/5/full
  129. Montgomery ET, Katz AWK, Duby Z, Mansoor LE, Morar NS, Naidoo K, et al. Men’s Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav. 2021 Jun;25(6):1890–900.